Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G MacKenzie

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|November 25, 1994
Studies of the active conformation of a novel series of benzamide dopamine D2 agonistsD J Wustrow, L D Wise, D M Cody, et al.
Journal of Medicinal Chemistry|August 15, 1997
Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
European Journal of Pharmacology|August 14, 1991
Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cellsM E Steffey, G L Snyder, R W Barrett, et al.
European Journal of Pharmacology|November 16, 1993
Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligandG Damsma, T Bottema, B H Westerink, et al.
Journal of Medicinal Chemistry|June 6, 1997
Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonistsS A Glase, H C Akunne, L M Georgic, et al.
Journal of Medicinal Chemistry|December 24, 1997
(Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
European Journal of Pharmacology|August 3, 1989
A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptorD J Kerkman, M Ackerman, L D Artman, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907T A Pugsley, M D Davis, H C Akunne, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|November 25, 1994
Studies of the active conformation of a novel series of benzamide dopamine D2 agonistsD J Wustrow, L D Wise, D M Cody, et al.
Journal of Medicinal Chemistry|August 15, 1997
Chromeno[3,4-c]pyridin-5-ones: selective human dopamine D4 receptor antagonists as potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
European Journal of Pharmacology|August 14, 1991
Dopamine D1 receptor stimulation of cyclic AMP accumulation in COS-1 cellsM E Steffey, G L Snyder, R W Barrett, et al.
European Journal of Pharmacology|November 16, 1993
Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligandG Damsma, T Bottema, B H Westerink, et al.
Journal of Medicinal Chemistry|June 6, 1997
Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonistsS A Glase, H C Akunne, L M Georgic, et al.
Journal of Medicinal Chemistry|December 24, 1997
(Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agentsP C Unangst, T Capiris, D T Connor, et al.
European Journal of Pharmacology|August 3, 1989
A-69024: a non-benzazepine antagonist with selectivity for the dopamine D-1 receptorD J Kerkman, M Ackerman, L D Artman, et al.
Journal of Medicinal Chemistry|August 2, 1996
Aryl 1-but-3-ynyl-4-phenyl-1,2,3,6-tetrahydropyridines as potential antipsychotic agents: synthesis and structure-activity relationshipsS A Glase, H C Akunne, T G Heffner, et al.
Journal of Medicinal Chemistry|December 22, 1995
Identification, characterization and pharmacological profile of three metabolites of (R)-(+)-1,2,3,6-tetrahydro-4-phenyl-1-[(3-phenylcyclohexen-1- yl)methyl]pyridine (CI-1007), a dopamine autoreceptor agonist and potential antipsychotic agentJ L Wright, D M Downing, M R Feng, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1995
Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907T A Pugsley, M D Davis, H C Akunne, et al.
Pageof 8